Dimethylformamide → N-[1-(4-chlorophenyl)-5-isopropylpyrazol-4-yl]-2-[2-methyl-4-(trifluoromethyl)-5-vinyl-imidazol-1-yl]pent-4-enamide
Reaction equation
[CH3:1][C:2]1[N:3]([CH:13]([CH2:17][CH:18]=[CH2:19])[C:14]([OH:16])=O)[C:4]([CH:11]=[CH2:12])=[C:5]([C:7]([F:10])([F:9])[F:8])[N:6]=1.CN(C=O)C.[Cl:25][C:26]1[CH:31]=[CH:30][C:29]([N:32]2[C:36]([CH:37]([CH3:39])[CH3:38])=[C:35]([NH2:40])[CH:34]=[N:33]2)=[CH:28][CH:27]=1.CN(C(ON1N=NC2C=CC=NC1=2)=[N+](C)C)C.F[P-](F)(F)(F)(F)F>O.CCN(CC)CC>[Cl:25][C:26]1[CH:27]=[CH:28][C:29]([N:32]2[C:36]([CH:37]([CH3:38])[CH3:39])=[C:35]([NH:40][C:14](=[O:16])[CH:13]([N:3]3[C:4]([CH:11]=[CH2:12])=[C:5]([C:7]([F:8])([F:9])[F:10])[N:6]=[C:2]3[CH3:1])[CH2:17][CH:18]=[CH2:19])[CH:34]=[N:33]2)=[CH:30][CH:31]=1Participants
7
Reactant 4
Product 1
Reagents, catalysts & solvents 2
Procedure
To 2-[2-methyl-4-(trifluoromethyl)-5-vinylimidazol-1-yl]pent-4-enoic acid (120 mg, 0.42 mmol) was added DMF (3 mL), Et3N (500 μL, excess), 1-(4-chlorophenyl)-5-isopropylpyrazol-4-amine (100 mg, 0.42 mmol), and HATU (250 mg, excess) and the resulting mixture was stirred at room temperature for 1 h. Water (20 mL) was added and the mixture was extracted with EtOAc (2×50 mL). The combined organics were then dried (MgSO4), concentrated in vacuo, and purified by flash chromatography (SiO2, 80% EtOAc/hexanes) to obtain N-[1-(4-chlorophenyl)-5-isopropylpyrazol-4-yl]-2-[2-methyl-4-(trifluoromethyl)-5-vinylimidazol-1-yl]pent-4-enamide (147 mg, 0.3 mmol, 70% yield).
Workup
- extractionthe mixture was extracted with EtOAc (2×50 mL)
- dry with materialThe combined organics were then dried (MgSO4)
- concentrationconcentrated in vacuo
- custompurified by flash chromatography (SiO2, 80% EtOAc/hexanes)
Sources & evidence
- ORD record
- ord-299af22cc8314be9a40fcc01f3713012
- Source dataset
- uspto-grants-2015_10
- Patent number
- US09169248B2
Reaction notes
Loading…